BARRINGTON, Illinois (August 2, 2022) — The great majority of rosacea patients have experienced persistent facial redness, and most of them report it is the most frequently bothersome sign they face, according to a recent National Rosacea Society (NRS) survey on rosacea redness sponsored by EPI Health. Furthermore, two-thirds reported experiencing flare-ups more than once a week.

CHICAGO (April 1, 2022) — Thanks to the growing number of sophisticated rosacea therapies, the 16 million Americans with this potentially serious facial disorder who commit to partnering with their physicians can now expect to enjoy a clear complexion without the psychological and emotional burden of its unpredictable and embarrassing effects.

BARRINGTON, Illinois (February 8, 2022) — Sophisticated new therapies designed to target rosacea's disease processes combined with treatment plans tailored to patients’ specific cases have made it easier than ever for sufferers to achieve clear skin. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on the treatments available for this potentially serious disorder, as well as the importance of a key factor in making them effective: the patient’s ongoing commitment to comply with therapy.

BARRINGTON, Illinois (January 25, 2022) — A pair of new studies help establish the relative prevalence of signs and symptoms of the eyes of rosacea patients (ocular rosacea), as well as the importance of medical therapy.

BARRINGTON, Illinois (Nov. 9, 2021) — The National Rosacea Society (NRS) has awarded funding for two new studies in addition to continuing support for two ongoing studies as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.

BARRINGTON, Illinois (August 23, 2021) — New recommendations urging dermatologists to place greater emphasis on persistent facial erythema in rosacea were recently published in the Journal of Drugs in Dermatology.¹ Titled “Update on Facial Erythema in Rosacea,” the new publication is based on a recent National Rosacea Society (NRS) roundtable to discuss this key aspect of the disorder in light of its recently updated standard classification system and standard management options, new burden-of-illness study results, and significant advances in medical th

BARRINGTON, Illinois (June 15, 2021) — The fact that certain foods can trigger a flare-up in some rosacea patients is well known. In reaction to these foods and other environmental factors such as sun exposure or extreme temperatures, the body releases substances in the skin that cause a chain reaction that leads to flushing, inflammation and, for some, burning and stinging sensations.

BARRINGTON, Illinois (April 22, 2021) — The National Rosacea Society recently conducted a survey focused on how rosacea impacts the social lives of patients. More than 575 people with rosacea took part in the survey, and 85% of the respondents said a flare-up of rosacea frequently or occasionally brings them unwanted attention. Ninety-one percent said this unwanted attention affects how they perceive themselves.

CHICAGO (April 1, 2021) – While protective face masks may both hide and exacerbate the signs and symptoms of rosacea, the 16 million Americans who suffer from this red-face disorder now have access to more treatment options and sophisticated medical care than ever before. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on this unsightly and potentially serious facial condition, and to urge those who suspect they may have it to see a dermatologist for diagnosis and the most up-to-date therapy.

Barrington, Illinois (March 9, 2021) — The National Rosacea Society today announced it has introduced an updated version of “Understanding Rosacea,” its most popular educational booklet that provides an introduction to this chronic facial skin disorder estimated to affect more than 16 million Americans. The new edition incorporates the updated standard classification and pathophysiology of rosacea, developed by a consensus committee and review panel of 28 rosacea experts worldwide and published in the Journal of the American Academy of Dermatology.

BARRINGTON, Illinois (February 9, 2021) – Although rosacea sufferers now have access to more treatment options and sophisticated care than ever before, many are still untreated or using older therapies that may not be optimally suited for their individual cases.

BARRINGTON, Illinois (January 26, 2021) — Although many of the most commonly prescribed treatments for rosacea are oral or topical antibiotics, a recent survey by the National Rosacea Society (NRS) found the majority of rosacea patients have never heard of antibiotic resistance — the development of harmful bacteria unaffected by antibiotics.

BARRINGTON, Illinois (Nov. 23, 2020) — The National Rosacea Society has awarded funding for two new studies, in addition to continuing support for one ongoing study, as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.

BARRINGTON, Illinois (October 5, 2020) — A recent National Rosacea Society (NRS) survey found that most rosacea patients were satisfied with the oral and topical prescription therapies they are using to treat this chronic facial skin disorder, but that individuals 60 and over were more likely to use older treatments, rather than newer products that may more effectively target specific signs and symptoms.

BARRINGTON, Illinois (May 11, 2020) — New developments in rosacea call for dermatologists to place greater emphasis on addressing persistent facial erythema, according to experts at a recent National Rosacea Society (NRS) roundtable to provide an update on this key aspect of the disorder, based on the new standard classification system, recent burden-of-illness study results, new standard management options and significant advances in medical therapy and patient care.

CHICAGO (April 1, 2020) – Increased medical understanding has led to significant advances in the control of rosacea, allowing many of those who suffer from this chronic red-faced disorder to live free of its conspicuous and embarrassing symptoms for the first time.

BARRINGTON, Illinois (February 19, 2020) — A new generation of therapies has resulted in dramatic advances in the management of rosacea, allowing many of the estimated 16 million Americans who suffer from this chronic disorder to live free of its often life-disruptive signs and symptoms. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on the current understanding of this complex condition, urging those who believe they may have rosacea to see a dermatologist for diagnosis and appropriate therapy.

BARRINGTON, Illinois (August 14, 2019) — The National Rosacea Society has introduced an innovative public service booklet called “Recognizing Redness” to help rosacea sufferers assess facial redness, the primary diagnostic feature of this chronic facial skin disorder that affects more than 16 million Americans. The booklet includes a redness register to allow patients to gauge relative redness before and after flare-ups or treatment.

BARRINGTON, Illinois (June 3, 2019) — A recent National Rosacea Society (NRS) survey found that highly successful medical treatment for rosacea often has a major positive impact on patients’ lives.

In the survey of 1,044 rosacea patients, around 76 percent of all respondents saw at least some improvement in their skin after receiving treatment. Among those patients, 40 percent said that treatment had improved their psychological well-being, 35 percent said their social well-being had improved, and 31 percent saw improvement in their occupational well-being.